Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-48,200
Closed -$8.22M 10725
2026
Q1
$8.22M Sell
48,200
-1,800
-4% -$351K ﹤0.01% 3561
2025
Q4
$11.3M Sell
50,000
-16,700
-25% -$3.63M ﹤0.01% 3164
2025
Q3
$12.7M Buy
66,700
+49,200
+281% +$8.95M ﹤0.01% 3036
2025
Q2
$2.76M Buy
+17,500
New +$2.63M ﹤0.01% 4481
2020
Q4
Sell
-16,400
Closed -$2.58M 8557
2020
Q3
$2.58M Buy
+16,400
New +$2.57M ﹤0.01% 2809
2020
Q1
Sell
-951,700
Closed -$147M 8168
2019
Q4
$147M Buy
+951,700
New +$139M 0.05% 332
2019
Q3
Sell
-208,900
Closed -$33.6M 8121
2019
Q2
$33.6M Buy
+208,900
New +$29.3M 0.01% 890
2015
Q1
Sell
-100
Closed -$6K 9049
2014
Q4
$6K Buy
+100
New +$5.71K ﹤0.01% 8833

Other funds holding IQV

UBS Group's IQV Position: Q2 2026 in Review

UBS Group reduced its IQVIA (IQV) stake by 38% in Q2 2026, selling an estimated $50.9M and leaving 478,857 shares worth $92.5M. The position accounts for 0.01% of the portfolio, ranked #1178.

UBS Group first reported a position in IQV in Q4 2014 and has held it in 47 quarters since. The position peaked at $189M in Q3 2025. 1,090 funds tracked by Wall St. Rank hold IQV as of Q2 2026.

  • UBS Group held 478,857 shares of IQVIA worth $92.5M as of Q2 2026.
  • UBS Group sold 292,009 IQVIA shares in Q2 2026, an estimated $50.9M.
  • IQVIA made up 0.01% of UBS Group's portfolio in Q2 2026, its #1178 holding.
  • UBS Group first reported a position in IQVIA in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's IQVIA position peaked at $189M in Q3 2025.
  • 1,090 funds tracked by Wall St. Rank held IQVIA as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.